AccuStem Sciences, Inc.
ACUT
$0.90
$0.089.44%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.03% | 6.50% | 18.64% | 26.60% | 50.45% |
| Total Depreciation and Amortization | -63.89% | -38.89% | -16.67% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 460.03% | 444.65% | 441.50% | 286.01% | -29.20% |
| Change in Net Operating Assets | -0.43% | 37.72% | 20.47% | 51.40% | -53.15% |
| Cash from Operations | 9.09% | 55.53% | 49.04% | 58.89% | 50.62% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -11.98% | -53.90% | -44.54% | -37.35% | 23.36% |
| Total Debt Repaid | 33.60% | 54.73% | 64.67% | 61.19% | 19.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.20% | -53.71% | -39.79% | -28.28% | 35.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.04% | 80.27% | 115.77% | 97.70% | 97.31% |